CNS Pharmaceuticals, Inc. (CNSP) symbol metrics page

Cns Pharmaceuticals Inc. (CNSP) NASDAQ

$0.23 0.03 (12.83%)

Market Cap: $2.12M

As of 05/16/24 02:12 PM EDT. Market closed.

Cns Pharmaceuticals Inc. (CNSP)
NASDAQ

$0.23
0.03 (12.83%)

Market Cap: $2.12M

As of 05/16/24 02:12 PM EDT. Market closed.

Add to Portfolio

cns pharmaceuticals, inc., a biopharmaceutical company, engages in the development of anti-cancer drug candidates for primary and metastatic cancers of the brain and central nervous system. the company's lead drug candidate is berubicin, which completed phase i clinical trial that is used for the treatment of glioblastoma multiforme. it has license agreements with houston pharmaceuticals, inc. ... read more

COMPANY PROFILE

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

URL

Address

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Full Time Employees

URL

Address

PRICE CHART FOR CNS PHARMACEUTICALS INC

YTD

MAX

From: To:

NEWS

INSIDEARBITRAGE ARTICLES

KEY STATS

Open

$0.23

Previous Close

$0.20

Days Range

$0.19 - $0.21

52 week range

$0.19 - $2.98

Volume

327,528

Avg. Volume (30 days)

327,001

Market Cap

$2.12M

Dividend Yield

P/E

Shares Outstanding

10,634,932

Open

$0.23

Previous Close

$0.20

Days Range

$0.19 - $0.21

52 week range

$0.19 - $2.98

Volume

327,528

Avg. Volume (30 days)

327,001

Market Cap

$2.12M

Dividend Yield

P/E

Shares Outstanding

10,634,932

FINANCIAL STATEMENTS FOR CNS PHARMACEUTICALS INC

Open in:

INSIDER TRANSACTIONS FOR CNS PHARMACEUTICALS INC

Owner	Relationship	Date	Transaction	Cost	# Shares	Value($)	Total Shares	Form 4
Gumulka Jerzy	Director	Feb 01, 2024	Buy	$0.30	33,333	10,000	43,006	Feb 06, 2024, 10:28 AM
Evans Carl Anthony	Director	Feb 01, 2024	Buy	$0.30	33,333	10,000	33,458	Feb 06, 2024, 10:27 AM
Downs Christopher	Chief Financial Officer	Feb 01, 2024	Buy	$0.30	66,666	20,000	103,438	Feb 06, 2024, 10:27 AM
Climaco John M	Chief Executive Officer	Feb 01, 2024	Buy	$0.30	166,666	50,000	215,676	Feb 06, 2024, 10:27 AM
Downs Christopher	Chief Financial Officer	Aug 22, 2023	Buy	$1.27	27,000	34,177	36,772	Aug 23, 2023, 08:00 AM
Climaco John M	Chief Executive Officer	Aug 16, 2023	Buy	$1.80	2,750	4,944	49,010	Aug 16, 2023, 04:01 PM
Priebe Waldemar	10% Owner	Mar 13, 2023	Sale	$1.30	5,000	6,500	221,807	Aug 01, 2023, 05:10 PM
Priebe Waldemar	10% Owner	Mar 21, 2023	Sale	$1.10	5,000	5,500	191,807	Aug 01, 2023, 05:10 PM
Priebe Waldemar	10% Owner	Mar 10, 2023	Sale	$1.29	5,000	6,450	226,807	Aug 01, 2023, 05:10 PM
Priebe Waldemar	10% Owner	Mar 20, 2023	Sale	$1.08	5,000	5,400	196,807	Aug 01, 2023, 05:10 PM
Priebe Waldemar	10% Owner	Mar 28, 2023	Sale	$1.04	10,000	10,400	156,807	Aug 01, 2023, 05:10 PM
Priebe Waldemar	10% Owner	Dec 09, 2022	Sale	$2.43	2,798	6,799	231,807	Aug 01, 2023, 05:10 PM
Priebe Waldemar	10% Owner	Mar 17, 2023	Sale	$1.13	5,000	5,650	201,807	Aug 01, 2023, 05:10 PM
Priebe Waldemar	10% Owner	Mar 27, 2023	Sale	$1.09	5,000	5,450	166,807	Aug 01, 2023, 05:10 PM
Priebe Waldemar	10% Owner	Dec 08, 2022	Sale	$2.40	5,500	13,200	234,605	Aug 01, 2023, 05:10 PM
Priebe Waldemar	10% Owner	Mar 16, 2023	Sale	$1.24	5,000	6,200	206,807	Aug 01, 2023, 05:10 PM
Priebe Waldemar	10% Owner	Mar 24, 2023	Sale	$1.08	5,000	5,400	171,807	Aug 01, 2023, 05:10 PM
Priebe Waldemar	10% Owner	Dec 07, 2022	Sale	$2.46	5,500	13,530	240,105	Aug 01, 2023, 05:10 PM
Priebe Waldemar	10% Owner	Mar 15, 2023	Sale	$1.22	5,000	6,100	211,807	Aug 01, 2023, 05:10 PM
Priebe Waldemar	10% Owner	Mar 23, 2023	Sale	$1.08	10,000	10,800	176,807	Aug 01, 2023, 05:10 PM
Priebe Waldemar	10% Owner	Dec 06, 2022	Sale	$2.47	5,500	13,585	245,605	Aug 01, 2023, 05:10 PM
Priebe Waldemar	10% Owner	Mar 14, 2023	Sale	$1.35	5,000	6,750	216,807	Aug 01, 2023, 05:10 PM
Priebe Waldemar	10% Owner	Mar 22, 2023	Sale	$1.08	5,000	5,400	186,807	Aug 01, 2023, 05:10 PM
Gumulka Jerzy	Director	Apr 19, 2023	Buy	$1.70	2,500	4,250	9,673	Apr 21, 2023, 07:58 AM
Downs Christopher	Chief Financial Officer	Apr 17, 2023	Buy	$3.20	3,100	9,920	9,251	Apr 18, 2023, 08:00 AM
Gumulka Jerzy	Director	Apr 10, 2023	Buy	$0.74	7,173	5,308	7,173	Apr 17, 2023, 08:17 AM
Climaco John M	Chief Executive Officer	Apr 12, 2023	Buy	$0.69	15,000	10,408	45,010	Apr 14, 2023, 04:20 PM
Downs Christopher	Chief Financial Officer	Mar 11, 2022	Option Exercise	$0.31	33,000	10,230	184,500	Mar 14, 2022, 09:40 AM
Keyes Jeffry R.	Director	Mar 07, 2022	Option Exercise	$0.30	11,100	3,294	11,100	Mar 09, 2022, 02:34 PM
Evans Carl Anthony	Director	Mar 08, 2022	Option Exercise	$0.27	3,750	1,005	3,750	Mar 09, 2022, 02:34 PM
Climaco John M	Chief Executive Officer	Mar 07, 2022	Option Exercise	$0.28	35,000	9,835	940,298	Mar 08, 2022, 08:30 AM
Downs Christopher	Chief Financial Officer	Dec 06, 2021	Buy	$0.94	5,000	4,701	151,500	Dec 07, 2021, 08:30 AM
Downs Christopher	Chief Financial Officer	Nov 19, 2021	Buy	$1.15	4,500	5,192	146,500	Nov 22, 2021, 08:47 AM
Climaco John M	Chief Executive Officer	Nov 16, 2021	Option Exercise	$1.28	5,000	6,400	905,298	Nov 18, 2021, 08:07 PM
Downs Christopher	Chief Financial Officer	Aug 24, 2020	Buy	$2.04	142,000	289,680	142,000	Aug 25, 2020, 07:11 PM

Load More Insider Transactions

Buy Sale Option Exercise

Owner	Relationship	Date	Value($)
Gumulka Jerzy	Director	02/01/2024	10,000
Evans Carl Anthony	Director	02/01/2024	10,000
Downs Christopher	Chief Financial Officer	02/01/2024	20,000
Climaco John M	Chief Executive Officer	02/01/2024	50,000
Downs Christopher	Chief Financial Officer	08/22/2023	34,177
Climaco John M	Chief Executive Officer	08/16/2023	4,944
Priebe Waldemar	10% Owner	03/13/2023	6,500
Priebe Waldemar	10% Owner	03/21/2023	5,500
Priebe Waldemar	10% Owner	03/10/2023	6,450
Priebe Waldemar	10% Owner	03/20/2023	5,400
Priebe Waldemar	10% Owner	03/28/2023	10,400
Priebe Waldemar	10% Owner	12/09/2022	6,799
Priebe Waldemar	10% Owner	03/17/2023	5,650
Priebe Waldemar	10% Owner	03/27/2023	5,450
Priebe Waldemar	10% Owner	12/08/2022	13,200
Priebe Waldemar	10% Owner	03/16/2023	6,200
Priebe Waldemar	10% Owner	03/24/2023	5,400
Priebe Waldemar	10% Owner	12/07/2022	13,530
Priebe Waldemar	10% Owner	03/15/2023	6,100
Priebe Waldemar	10% Owner	03/23/2023	10,800
Priebe Waldemar	10% Owner	12/06/2022	13,585
Priebe Waldemar	10% Owner	03/14/2023	6,750
Priebe Waldemar	10% Owner	03/22/2023	5,400
Gumulka Jerzy	Director	04/19/2023	4,250
Downs Christopher	Chief Financial Officer	04/17/2023	9,920
Gumulka Jerzy	Director	04/10/2023	5,308
Climaco John M	Chief Executive Officer	04/12/2023	10,408
Downs Christopher	Chief Financial Officer	03/11/2022	10,230
Keyes Jeffry R.	Director	03/07/2022	3,294
Evans Carl Anthony	Director	03/08/2022	1,005
Climaco John M	Chief Executive Officer	03/07/2022	9,835
Downs Christopher	Chief Financial Officer	12/06/2021	4,701
Downs Christopher	Chief Financial Officer	11/19/2021	5,192
Climaco John M	Chief Executive Officer	11/16/2021	6,400
Downs Christopher	Chief Financial Officer	08/24/2020	289,680

Load More Insider Transactions

FUNDS WITH A POSITION IN CNS PHARMACEUTICALS INC

Fund	# Shares Owned	% of Portfolio	% Change	Investing Style
GEODE CAPITAL MANAGEMENT, LLC	28,254	0%	15.62%	Other
RENAISSANCE TECHNOLOGIES LLC	11,144	0.00002%	Exited	Other

CHANGE IN SHARES OUTSTANDING FOR CNS PHARMACEUTICALS INC

STOCK BUYBACKS FOR CNS PHARMACEUTICALS INC

Period of Report

Previous Period

% Change in Shares

10-K/10-Q Filings

Quarter

12/31/2023

06/30/2023

-2.84%

View

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period

% Change in Shares

Quarter

06/30/2023

-2.84%

BUYBACK ANNOUNCEMENT(S) FOR CNS PHARMACEUTICALS INC

Active Completed

Looking for more premium content?